(Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|
Assets | ||||||||
Current assets | ||||||||
Cash, cash equivalents and short term investments | 40.45%82.72K | -10.44%92.33K | --92.33K | 8.16%100.78K | --36.25K | --58.89K | --103.1K | --93.18K |
-Cash and cash equivalents | 40.45%82.72K | -10.44%92.33K | --92.33K | 8.16%100.78K | --36.25K | --58.89K | --103.1K | --93.18K |
Current deferred assets | ---- | --0 | --0 | --0 | --10K | --10K | --10K | --10K |
Total current assets | 20.07%82.72K | -18.36%92.33K | --92.33K | -2.33%100.78K | --46.25K | --68.89K | --113.1K | --103.18K |
Non current assets | ||||||||
Liabilities | ||||||||
Current liabilities | ||||||||
-accounts payable | ---- | ---- | ---- | ---- | --77.37K | --71.9K | ---- | ---- |
-Total tax payable | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Current accrued expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --27.15K |
Current liabilities | -70.09%21.5K | -82.18%15.59K | --15.59K | -90.30%2.64K | --77.37K | --71.9K | --87.47K | --27.15K |
Non current liabilities | ||||||||
Total non current liabilities | -70.09%21.5K | -82.18%15.59K | --15.59K | -90.30%2.64K | --77.37K | --71.9K | --87.47K | --27.15K |
Shareholders'equity | ||||||||
Share capital | 114.36%246.75K | 114.36%246.75K | --246.75K | 134.75%246.75K | --115.11K | --115.11K | --115.11K | --105.11K |
-common stock | 114.36%246.75K | 114.36%246.75K | --246.75K | 134.75%246.75K | --115.11K | --115.11K | --115.11K | --105.11K |
Gains losses not affecting retained earnings | --32K | --32K | --32K | --32K | ---- | ---- | --0 | ---- |
Total equity | 20.07%82.72K | -18.36%92.33K | --92.33K | -2.33%100.78K | --46.25K | --68.89K | --113.1K | --103.18K |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.